AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $648,789 | -7.7% | 9,283 | -5.1% | 0.01% | 0.0% |
| Q2 2023 | $702,647 | +20.7% | 9,778 | +3.6% | 0.01% | +20.0% |
| Q1 2023 | $582,074 | -11.5% | 9,437 | +10.6% | 0.01% | -16.7% |
| Q4 2022 | $657,842 | +85.8% | 8,529 | +7.5% | 0.01% | +50.0% |
| Q3 2022 | $354,000 | +20.8% | 7,931 | +3.5% | 0.00% | +33.3% |
| Q2 2022 | $293,000 | +6.9% | 7,661 | +15.7% | 0.00% | +50.0% |
| Q1 2022 | $274,000 | +10.0% | 6,623 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | +13.7% | 6,592 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $219,000 | -50.8% | 6,652 | +0.8% | 0.00% | -50.0% |
| Q2 2021 | $445,000 | -3.7% | 6,598 | -19.1% | 0.00% | 0.0% |
| Q1 2021 | $462,000 | -30.1% | 8,153 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $661,000 | +10.5% | 8,109 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $598,000 | +16.3% | 8,391 | +34.2% | 0.01% | -14.3% |
| Q2 2020 | $514,000 | +53.9% | 6,252 | +10.2% | 0.01% | +16.7% |
| Q1 2020 | $334,000 | – | 5,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |